Visionsense

Visionsense is a medical technology company that develops advanced 3D visualization systems for minimally invasive surgery. The company's proprietary technology provides surgeons with natural stereoscopic vision and depth perception through extremely small access ports, enhancing precision in complex procedures. Its flagship products, such as the VS3 and Iridium systems, combine high-definition 3D imaging with integrated fluorescence to visualize tissue perfusion and anatomical structures in real-time. Visionsense was acquired by Medtronic in 2018 to integrate its advanced imaging capabilities into Medtronic's neurosurgery and ENT surgical navigation portfolios. This acquisition has enabled the broader adoption of 3D visualization in neurosurgical and skull-base procedures globally.